All News
Filter News
Found 808,440 articles
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Kaiser Health News recently published “Pharma Cash To Congress,” a campaign contributions tracker. KHN noted that, “Members of Congress raked in almost $4 million from the pharmaceutical manufacturers and their trade groups in the first six months of 2019.
-
The biopharma company will utilize Coursera’s enterprise platform, Coursera for Business, to offer educational programs to its 108,000 staffers around the world.
-
Career experts advocate having both a mentor and a sponsor.
-
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid
9/13/2019
Akari Therapeutics, Plc announced that the U.S. Food and Drug Administration has granted orphan drug designation for nomacopan for the treatment of bullous pemphigoid.
-
New Study Finds SkinVision Detects 95% of Skin Cancer
9/13/2019
An international group of researchers working with Erasmus University Medical Center in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer.
-
Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer
9/13/2019
Todos Medical Ltd. announced it has entered into a binding term sheet with HWH World Pte Ltd., a wholly-owned subsidiary of Singapore eDevelopment for the grant of exclusive marketing rights for Todos Medical’s TM-B1 and TM-B2 tests to HWH World’s network of members in Singapore, Malaysia, the Philippines, Vietnam, Thailand, Indonesia, South Korea, Hong Kong, China, the United States and Canada.
-
Latham & Watkins Advises Baxter International in Acquisition of Cheetah Medical
9/13/2019
Baxter International Inc., a leading global medical products company, has entered into a definitive agreement to acquire Cheetah Medical, an Israel-based leading provider of non-invasive hemodynamic monitoring technologies with offices in Boston, Massachusetts as well as Tel Aviv, as detailed in the company press release.
-
Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
9/13/2019
Auris Medical Holding Ltd. announced that it has obtained advice on the development plan and regulatory pathway for its investigational tinnitus treatment Keyzilen® from the U.S. Food and Drug Administration and from the European Medicines Agency.
-
Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis
9/13/2019
Mologic Ltd announced that it has finished recruitment to a major clinical trial with University College London Hospitals (UCLH) to evaluate the Company’s point-of-care (POC) diagnostic test for the early detection of sepsis.
-
The Asian Biopharma Market is Evolving | Infiniti Reveals the Key Biopharma Industry Trends in Asia
9/13/2019
A well-known market intelligence company, Infiniti Research, has announced the completion of their latest article on top trends shaping the Asian biopharma industry
-
Ambu AS, Stryker Corp., Intersurgical Ltd., and Medline Industries, and VYAIRE MEDICAL Compete for a Bigger Share of the Health Care Supplies Industry Reports Technavio
9/13/2019
Technavio’s market research reports examine the competitive landscape and provide detailed insights into the market scenario over the next five years
-
CBR to Acquire Natera's Evercord™ Cord Blood Business
9/13/2019
Natera, Inc. (NASDAQ: NTRA) and CBR (Cord Blood Registry) today announced the acquisition by CBR, a California Cryobank Life Sciences company, and the world's largest newborn stem cell collection and storage organization, of Natera's Evercord™ cord blood and tissue banking business.
-
CBR® Acquires Evercord™ Newborn Stem Cell Business from Natera
9/13/2019
CBR (Cord Blood Registry), the world's largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc.'s (NASDAQ: NTRA) Evercord™ newborn stem cell business.
-
NorthStar Medical Radioisotopes to Host Groundbreaking and Speaker Event Featuring Representatives from U.S. Department of Energy’s National Nuclear Security Administration, State of Wisconsin and Industry Experts
9/13/2019
NorthStar Medical Radioisotopes will host a ribbon-cutting, groundbreaking and speakers event, “Molybdenum-99: Domestic Radioisotope Production Now, Expansion for the Future,” at NorthStar corporate headquarters in Beloit, Wis
-
Synapse Recognized As Finalist For The PM360 Trailblazer Initiative Award In HCP Education
9/13/2019
Synapse Medical Communications (Synapse), a leader in analytics-driven commercialization solutions, announced that its "BiomARker Experience Augmented Reality" application has been named a finalist for the 2019 PM360 Trailblazer Initiative Awards, in the Healthcare Provider Education category.
-
Zeta Phi Beta Sorority, Inc. Fights Against Birth Inequity, Raising Over $700,000 for March of Dimes
9/13/2019
Zeta Phi Beta Sorority, Inc., an international women's service organization and 47-year partner with the March of Dimes, was recognized by March of Dimes president, Stacey Stewart, for winning the "March of Dimes Gwen Carmen Alpha Phi Alpha/Zeta Phi Beta Challenge Award" on Sept. 10 at a reception held at the sorority's headquarters in Washington D.C
-
MMRF Research Programs Drives New Breakthroughs in Multiple Myeloma Research
9/13/2019
Today, the Multiple Myeloma Research Foundation (MMRF) announced the presentation of twenty-four research abstracts at the 17th International Myeloma Workshop in Boston.
-
HHS Office of Inspector General Report Shows Rebates Reduced Medicare Part D Drug Spending
9/13/2019
Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Officer of Inspector General report (OIG) on prescription drug rebates in Medicare Part D.
-
Novartis AG and Pfizer Inc. Compete for a Bigger Share of the Pharmaceuticals Market Reports Technavio
9/13/2019
Technavio’s market research reports examine the competitive landscape and provide detailed insights into the market scenario over the next five years.